UT Health San Antonio to Lead $11 Million, NIH-Funded Study of a First-Ever Oral Chlamydia Vaccine
May 10, 2024
May 10, 2024
SAN ANTONIO, Texas, May 10 (TNSres) -- The University of Texas Health Science Center at San Antonio issued the following news release:
By Steven Lee
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.
"We are excited about receiving the U01 award b . . .
By Steven Lee
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.
"We are excited about receiving the U01 award b . . .